Announcing a new article publication for BIO Integration journal. In this article the authors Haojie Yang, Yingzhe Yan, Qian Xie and colleagues from Sun Yat-sen University, Guangzhou, China and The ...

Facility-Level Disparities in Radiation Use for Limited-Stage Small Cell Lung Cancer Patient-controlled analgesia (PCA) has been considered for managing cancer pain; however, limited research has been ...

Findings showed after 52 weeks, significant improvements in 2MWD and 6MWD were seen with Flebogamma 5% DIF 1mg/kg compared with placebo. Topline data were announced from a phase 2/3 trial evaluating ...

Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia HELSINKI, 12 March 2026 - Aplagon, a ...

Please provide your email address to receive an email when new articles are posted on . Patients were treated with intravenous ertapenem for an average of 13.1 weeks. During a 7-week, posttherapy ...

Can you speak to the benefits and opportunities around innovating in that IV at home space? Around 30% of the compounds we'd like to move to subcutaneous delivery can't go for a variety of reasons.